Foamahol

Product NDC: 68654-585
11-digit product format: 686540585
Labeler code: 68654
Product ID: 68654-585_2e007cec-4db3-4991-99df-9bf2df750dcb
Type: HUMAN OTC DRUG
Nonproprietary name: ALCOHOL
Dosage form: LIQUID
Route: TOPICAL
Labeler: Share Corporation
Application: part333
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2009-09-01
Marketing end: 0000-00-00
Substance: ALCOHOL
Active strength: 1 mL/mL
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 21 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	68654-585		D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-01	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-03	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-05	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-06	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-07	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-08	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-09	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-10	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-11	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-12	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-13	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-14	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-15	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-16	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-17	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-18	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-24	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-27	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-28	D	Discontinued by firm	2026-10-05
excluded package	package	68654-585	68654-585-55	D	Discontinued by firm	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 8 · 462 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-18	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-17	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-06	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-07	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-16	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-10	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-09	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-05	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-27	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-12	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-14	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-55	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-13	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-24	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-28	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-03	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-11	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-08	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-15	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68654-585-01	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-18	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-17	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-06	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-07	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-16	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-10	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-09	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-05	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-27	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-12	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-14	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-55	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-13	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-24	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-28	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-03	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-11	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-08	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-15	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68654-585-01	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-13	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-27	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-12	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-55	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-16	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-11	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-17	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-09	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-28	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-24	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-05	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-15	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-10	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-06	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-14	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68654-585-07	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
68654-585-01	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-03	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-05	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-06	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-07	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-08	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-09	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-10	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-11	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-12	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-13	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-14	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-15	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-16	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-17	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-18	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-24	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-27	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-28	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-55	2025-03-31	Prevent 6585 Drug Facts and Label
68654-585-01	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-03	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-05	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-06	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-07	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-08	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-09	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-10	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-11	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-12	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-13	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-14	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-15	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-16	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-17	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-18	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-24	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-27	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-28	2020-01-31	Prevent 6585 Drug Facts and Label
68654-585-55	2020-01-31	Prevent 6585 Drug Facts and Label

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ALCOHOL	ACTIVE INGREDIENT	3K9958V90M	FOAMAHOL (ALCOHOL) LIQUID [SHARE CORPORATION]	1
ALCOHOL	ACTIVE MOIETY	3K9958V90M	FOAMAHOL (ALCOHOL) LIQUID [SHARE CORPORATION]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	FOAMAHOL (ALCOHOL) LIQUID [SHARE CORPORATION]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	FOAMAHOL (ALCOHOL) LIQUID [SHARE CORPORATION]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
3K9958V90M	ALCOHOL	64-17-5	ALCOHOL

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Prevent 6585 Drug Facts and Label	Share Corporation \| ABC Compounding Co., Inc.	2010-03-01	HUMAN OTC DRUG LABEL	1

Foamahol

NDC auxiliary status#

Observed NDC auxiliary status history#

Reported adverse events (FAERS/openFDA)#

FDA-Initiated Inactive NDC Indexing#

DailyMed Socrata Ingredients#

Related Records#

Related UNII Ingredients#

Related DailyMed Labels#